American National Registered Investment Advisor’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
American National Registered Investment Advisor's DGX Position: Q1 2022 in Review
American National Registered Investment Advisor reduced its Quest Diagnostics (DGX) stake by 2.2% in Q1 2022, selling an estimated $8.08K and leaving 2,553 shares worth $349K. The position accounts for 0.12% of the portfolio, ranked #198.
American National Registered Investment Advisor first reported a position in DGX in Q2 2013 and has held it in 36 quarters since. The position peaked at $452K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.
- American National Registered Investment Advisor held 2,553 shares of Quest Diagnostics worth $349K as of Q1 2022.
- American National Registered Investment Advisor sold 58 Quest Diagnostics shares in Q1 2022, an estimated $8.08K.
- Quest Diagnostics made up 0.12% of American National Registered Investment Advisor's portfolio in Q1 2022, its #198 holding.
- American National Registered Investment Advisor first reported a position in Quest Diagnostics in Q2 2013 and has held it in 36 quarters since.
- American National Registered Investment Advisor's Quest Diagnostics position peaked at $452K in Q4 2021.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.
Based on American National Registered Investment Advisor's 13F filing for Q1 2022, filed 13 May 2022.